샘플 요청 목록

 카트 문의
시장보고서
상품코드
1513897

세계의 원격 환자 모니터링 시스템 시장

Remote Patient Monitoring Systems
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 442 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

원격 환자 모니터링 시스템 세계 시장은 2030년까지 91억 달러에 이를 것으로 예상

2023년에 26억 달러로 추정되는 원격 환자 모니터링 시스템 세계 시장은 2023년부터 2030년까지 연평균 복합 성장률(CAGR) 19.6%로 성장하여 2030년에는 91억 달러에 이를 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 특수 모니터는 CAGR 18.9%로 성장을 지속하고, 분석 기간 종료 시 72억 달러에 도달할 것으로 예측됩니다. 바이탈 사인 모니터 분야의 성장률은 분석 기간 동안 CAGR 22.9%로 추정됩니다.

미국 시장은 추정 7억 2,060만 달러, 중국은 CAGR 18.6%로 성장 예측

미국의 원격 환자 모니터링 시스템 시장은 2023년 7억 2,060만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 14억 달러 규모에 이를 것으로 예측되며, 분석 기간 2023-2030년의 CAGR은 18.6%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 17.0%와 16.7%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 약 13.8%로 성장할 것으로 예측됩니다.

세계의 원격 환자 모니터링 시스템 시장 - 주요 동향 및 촉진요인 요약

원격 환자 모니터링(RPM) 시스템은 당뇨병 및 고혈압과 같은 만성 질환 관리에 필수적인 서비스를 제공하고 케어 제공을 강화하는 건강 관리에서 점점 더 중요 해지고 있습니다. 혈압계, 혈당계, 스마트 워치와 같은 고급 웨어러블과 같은 치료 장비를 이용하는 RPM 시스템은 건강 데이터의 지속적인 수집을 가능하게 하고, 의료 제공업체는 이를 이용하여 환자를 모니터링 그리고 그에 따라 치료 계획을 조정합니다. 설문조사는 입원기간의 단축과 치료의 적시 조정에 의한 만성질환 관리 개선 등 RPM의 장점을 강조하고 있습니다. 특히 팬데믹(세계적 유행)의 경우 RPM이 원격지에서 환자를 모니터링하고 병원 부담을 줄이는 데 매우 중요하다는 것이 입증되었습니다. 또, 병원 레벨의 치료를 재택 환자에게 제공하는 것으로, 긴급시의 진찰이나 입원을 줄이는 재택치료 프로그램에서도 효과를 발휘하고 있습니다.

RPM의 규제 상황은 급속히 진화하고 있으며, 특히 COVID-19 팬데믹 시에 부각된 요구가 박차를 가하고 있습니다. 메디케어 메디케이드 서비스센터(CMS)와 같은 기관이 RPM 이용을 확대하기 위한 새로운 정책과 면제조치를 도입함으로써 이러한 시스템은 보다 이용하기 쉬워져 다양한 헬스케어 환경에 적용할 수 있게 되었습니다. 미래를 전망할 때, 첨단 기술의 통합과 RPM의 장점에 대한 인식 증가는 유망한 미래를 가리킵니다. 이는 복잡한 사례를 원격으로 관리하기 위해 의료 시스템이 RPM을 채택하는 경우가 늘어나고 있기 때문에 분명하며, 물리적 건강 관리 시설에 대한 부담을 줄일 수 있습니다. 기술의 지속적인 발전과 추가 자금은 RPM 장비의 기능과 효율성을 향상시키고, 원격 모니터링이 현대 건강 관리 제공의 기초적인 측면이 되도록 합니다.

RPM 기술의 성장을 가속하는 여러 가지 요인이 있습니다. 데이터 분석과 AI 통합의 향상으로 환자 모니터링의 정확성이 향상되고 예측적인 의료 개입이 가능합니다. 5G와 같은 연결 솔루션의 개선은 RPM 장비에서 의료 제공업체로의 신뢰할 수 있는 데이터 전송을 보장합니다. 또한 소비자의 건강 의식도 크게 증가하고 있으며 실시간 건강 지표 피드백을 제공하는 건강 모니터링 장비에 대한 수요가 증가하고 있습니다. 웨어러블 기술의 인기는 지속적인 건강 추적을 정상화하고 RPM의 수용을 더욱 향상시키고 있습니다. 메디케어와 메디케이드를 포함한 보험업자의 지지적인 규제 틀과 상환 정책의 확대로 RPM 서비스는 보다 이용하기 쉽고 저렴합니다. 또한 원격 진료에 대한 환자의 요구와 업무 효율성을 위해 RPM을 채택한 의료 제공업체의 움직임은 보다 통합된 기술 중심의 환자 중심 의료 솔루션으로의 변화를 부각시키고 있습니다. 이러한 요인은 종합적으로 RPM 시스템의 도입과 효율성을 높이고 의료 관리 기법의 지속적인 변화를 반영합니다.

조사 대상 기업 예(총 162건)

  • Biotronik SE & Co. KG
  • F. Hoffmann-La Roche AG
  • Intel Corporation
  • Johnson & Johnson
  • Koninklijke Philips NV
  • Medtronic of Canada Ltd.
  • Philips Healthcare
  • Robert Bosch GmbH
  • Welch Allyn, Inc.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 세계 기타 지역

제4장 경쟁

JHS 24.07.24

Global Remote Patient Monitoring Systems Market to Reach US$9.1 Billion by 2030

The global market for Remote Patient Monitoring Systems estimated at US$2.6 Billion in the year 2023, is expected to reach US$9.1 Billion by 2030, growing at a CAGR of 19.6% over the analysis period 2023-2030. Special Monitors, one of the segments analyzed in the report, is expected to record a 18.9% CAGR and reach US$7.2 Billion by the end of the analysis period. Growth in the Vital Sign Monitors segment is estimated at 22.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$720.6 Million While China is Forecast to Grow at 18.6% CAGR

The Remote Patient Monitoring Systems market in the U.S. is estimated at US$720.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 18.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 17.0% and 16.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.8% CAGR.

Global Remote Patient Monitoring Systems Market - Key Trends and Drivers Summarized

Remote Patient Monitoring (RPM) systems are increasingly critical in healthcare, providing vital services for the management of chronic diseases like diabetes and hypertension and enhancing care delivery. Utilizing devices such as blood pressure monitors, blood glucose meters, and advanced wearables like smartwatches, RPM systems allow continuous collection of health data, which healthcare providers use to monitor patients and adjust treatment plans accordingly. Research has highlighted the benefits of RPM, including reducing hospital stay lengths and improving the management of chronic diseases by facilitating timely adjustments in treatment. Especially evident during the pandemic, RPM proved crucial for monitoring patients remotely, alleviating hospital burdens, and has been effective in hospital-at-home programs, which deliver hospital-level care to patients at home, thereby reducing emergency visits and hospitalizations.

The regulatory landscape for RPM has evolved rapidly, particularly spurred by the needs highlighted during the COVID-19 pandemic. Changes by entities like the Centers for Medicare and Medicaid Services (CMS), which introduced new policies and waivers to broaden RPM usage, have made these systems more accessible and applicable across various healthcare settings. Looking forward, the integration of advanced technologies and a growing recognition of the benefits of RPM point to a promising future. This is evidenced by the increasing adoption of RPM by health systems to manage complex cases remotely, thus reducing pressure on physical healthcare facilities. Continued advancements in technology and additional funding are enhancing the capabilities and efficiency of RPM devices, ensuring that remote monitoring remains a foundational aspect of modern healthcare delivery.

Several factors are driving the growth of RPM technology. Enhanced data analytics and AI integration improve patient monitoring accuracy, enabling predictive healthcare interventions. Improvements in connectivity solutions, such as 5G, ensure reliable data transmission from RPM devices to healthcare providers. There's also a significant increase in consumer health awareness, which has boosted demand for health monitoring devices providing real-time health metrics feedback. The popularity of wearable technologies has normalized continuous health tracking, further aiding RPM acceptance. Supportive regulatory frameworks and expanded reimbursement policies by insurance providers, including Medicare and Medicaid, are making RPM services more accessible and affordable. Additionally, patient demand for remote care options and healthcare providers' adoption of RPM for operational efficiency highlight the shift towards more integrated, technology-driven, and patient-centered healthcare solutions. These factors collectively enhance the adoption and effectiveness of RPM systems, reflecting an ongoing transformation in healthcare management practices.

Select Competitors (Total 162 Featured) -

  • Biotronik SE & Co. KG
  • F. Hoffmann-La Roche AG
  • Intel Corporation
  • Johnson & Johnson
  • Koninklijke Philips NV
  • Medtronic of Canada Ltd.
  • Philips Healthcare
  • Robert Bosch GmbH
  • Welch Allyn, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Remote Patient Monitoring Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Demand for Telehealth and Remote Healthcare Solutions
    • Growth of the Aging Population and Chronic Disease Management
    • Advancements in Remote Monitoring Technologies and Wearable Devices
    • Rising Adoption of Remote Patient Monitoring in Post-Acute Care
    • Impact of COVID-19 Pandemic on Healthcare Delivery and Remote Monitoring
    • Government Regulations and Standards for Telehealth and Remote Monitoring
    • Expansion of Remote Monitoring Applications in Home Healthcare
    • Development of Integrated and Real-Time Health Monitoring Platforms
    • Role of Remote Monitoring in Enhancing Patient Outcomes and Healthcare Efficiency
    • Market Penetration of Remote Monitoring in Rural and Underserved Areas
    • Influence of Technological Innovations on Data Accuracy and Connectivity
    • Growth of Remote Monitoring Applications in Chronic Disease Management
    • Challenges Related to Data Security and Patient Privacy Concerns
    • Emerging Markets and Growth Opportunities in Developing Regions
    • Future Trends and Innovations in Remote Patient Monitoring Systems and Healthcare Delivery
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Vital Sign Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Vital Sign Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Vital Sign Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Special Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Special Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Special Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Cardiovascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Sleep Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Sleep Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Sleep Disorder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Hospital based Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Hospital based Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Hospital based Patients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Ambulatory Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Ambulatory Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Ambulatory Patients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for Home Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Hypertension by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Hypertension by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 33: World 16-Year Perspective for Hypertension by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 34: World Remote Patient Monitoring Systems Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Remote Patient Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Remote Patient Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • JAPAN
    • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • CHINA
    • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • EUROPE
    • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Remote Patient Monitoring Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Remote Patient Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: France 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • GERMANY
    • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of World 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제